We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Biocatalytic strategies for the degradation of emerging micropollutants: From nanoplastics to pharmaceuticals
Summary
Researchers demonstrated that specific bacteria can break down both nanoplastics and common pharmaceuticals such as paracetamol and ibuprofen, which frequently contaminate waterways. Encasing these bacteria in alginate beads improved their stability and reusability, pointing toward practical bioremediation tools for tackling multiple classes of emerging pollutants simultaneously.
The increasing presence of micropollutants such as nanoplastics, microplastics, and pharmaceuticals poses a growing environmental concern. While enzymatic degradation strategies show promise, extending their application beyond PET plastics and fully elucidating pharmaceutical degradation pathways remains challenging. This work focuses on widely used pharmaceuticals—paracetamol, enalapril, ibuprofen, and atenolol—frequently detected in aquatic environments. We demonstrate the degradation capacity of bacteria from the genera Alcanivorax, Paraburkholderia, and Pseudomonas. Additionally, an alginate-based immobilization strategy enables complete paracetamol degradation while improving stability, reusability, and process efficiency.
Sign in to start a discussion.
More Papers Like This
Biocatalytic strategies for the degradation of emerging micropollutants: From nanoplastics to pharmaceuticals
Researchers demonstrated that specific bacteria can break down both nanoplastics and common pharmaceuticals such as paracetamol and ibuprofen, which frequently contaminate waterways. Encasing these bacteria in alginate beads improved their stability and reusability, pointing toward practical bioremediation tools for tackling multiple classes of emerging pollutants simultaneously.
Microbes as Biocatalysts of Marine Micropollutants
This review examines how marine microorganisms can serve as biocatalysts to break down micropollutants including industrial chemicals, pharmaceuticals, and microplastics in ocean environments. The study highlights advances in synthetic biology and genomics that are improving microbial efficiency for targeted bioremediation, while noting the need for cooperation among scientists, policymakers, and industry to address implementation challenges.
Characterization of microplastics and their interaction with antibiotics in wastewater
Researchers characterized microplastics in wastewater and investigated their interactions with antibiotics, examining how microplastic surfaces adsorb antibiotic compounds and the implications for antibiotic transport and dissemination in wastewater treatment systems.
Microbial–Enzymatic Combinatorial Approach to Capture and Release Microplastics
Researchers developed a microbial-enzymatic approach using evolved Pseudomonas aeruginosa to aggregate microplastics via biofilm formation for removal from polluted waters, then employed protease treatment to release captured plastics for downstream recovery.
Biodegradation and bioaugmentation of the co-contamination of chloramphenicol and microplastics by Exiguobacterium sp. CAP4 isolated from a contaminated plastisphere
Scientists isolated a bacterium called Exiguobacterium sp. CAP4 that can break down both microplastics and the antibiotic chloramphenicol at the same time in contaminated wastewater. This is significant because microplastics and antibiotics often pollute water together, and finding organisms that can degrade both could help clean up water supplies that people depend on.